LIVE: Trump Participates in a Health Care Affordability Event

Why It Matters

If realized, the pricing agreements and pharma investments could materially lower drug costs for many U.S. patients and shift global pricing dynamics; the moves also reinforce drug-pricing as a central political issue ahead of upcoming elections. Confidence: 85.

Summary

Former President Donald Trump hosted a health-care affordability event to announce that Regeneron has agreed to sell new and some existing medicines at “most favored nation” prices, joining a cohort of 17 pharma firms he said represent 80% of the branded drug market. He touted sweeping price cuts — citing specific examples like a cholesterol drug falling from $537 to $225 and a popular weight-loss drug dropping to as low as $199 — and said these deals will produce the largest reduction in U.S. prescription drug prices in history. Regeneron also pledged $27 billion for U.S. R&D and manufacturing, and Trump highlighted FDA approval of a Regeneron gene therapy for congenital deafness that the company will provide free for an initial period, showcased by a two-year-old patient who regained hearing. The event mixed policy announcements with political messaging and featured administration officials and company executives on stage.

Original Description

Watch live from the Oval Office as President Donald Trump participates in a health care affordability event